The results of GSVA and GSEA demonstrated that majority of cancer hallmark signatures were significantly enriched in high AURKA HCC, such as PI3K–AKT–MTOR signaling (12) (a classical downstream cascade of AURKA; Fig. 3, A–C). This evidence concerns the gene MTOR and hepatocellular carcinoma.